SG Americas Securities LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 78.7% during the fourth quarter, HoldingsChannel reports. The fund owned 106,106 shares of the exchange traded fund’s stock after purchasing an additional 46,718 shares during the quarter. SG Americas Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $9,556,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Tidemark LLC raised its stake in shares of SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after purchasing an additional 199 shares in the last quarter. Quintet Private Bank Europe S.A. acquired a new position in SPDR S&P Biotech ETF in the third quarter worth approximately $40,000. ORG Wealth Partners LLC bought a new position in SPDR S&P Biotech ETF during the third quarter valued at approximately $44,000. Howe & Rusling Inc. acquired a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $49,000. Finally, Waldron Private Wealth LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter worth approximately $54,000.
SPDR S&P Biotech ETF Trading Up 1.9 %
SPDR S&P Biotech ETF stock opened at $92.98 on Friday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The firm’s fifty day simple moving average is $93.33 and its 200-day simple moving average is $96.88. The company has a market capitalization of $7.09 billion, a P/E ratio of 11.47 and a beta of 1.11.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- How to Plot Fibonacci Price Inflection Levels
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- What is Insider Trading? What You Can Learn from Insider Trading
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.